Doron Blachar - 29 Sep 2025 Form 4 Insider Report for ORMAT TECHNOLOGIES, INC. (ORA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
30 Sep 2025, 21:56:53 UTC
Prior SEC filing
25 Mar 2025
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jessica Woelfel - as attorney-in-fact

Key filing fact

Doron Blachar filed Form 4 for ORMAT TECHNOLOGIES, INC. (ORA) on 30 Sep 2025.

Key facts

  • This page summarizes Doron Blachar's Form 4 filing for ORMAT TECHNOLOGIES, INC. (ORA).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 30 Sep 2025, 21:56.

Change

  • Previous filing in this sequence was filed on 25 Mar 2025.
  • Current net transaction value: -$1,420,378.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001571480 Primary reporting owner

Blachar Doron

Relationship
Chief Executive Officer
Address
C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO
Signature
/s/ Jessica Woelfel - as attorney-in-fact
Signature date
30 Sep 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ORA transaction

Common Stock

Options Exercise

Transaction value
$2,876,141
Shares
+45,365
Change %
+128%
Price
$63.40
Shares after
80,784
Date
29 Sep 2025
Ownership
Direct
Footnotes
F1
ORA transaction

Common Stock

Disposed to Issuer

Transaction value
$2,876,437
Shares
-30,371
Change %
-38%
Price
$94.71
Shares after
50,413
Date
29 Sep 2025
Ownership
Direct
Footnotes
F2
ORA transaction

Common Stock

Sale

Transaction value
$1,420,082
Shares
-14,994
Change %
-30%
Price
$94.71
Shares after
35,419
Date
29 Sep 2025
Ownership
Direct
Footnotes
F3, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORA transaction Derivative

Stock Appreciation Rights (SARs)

Options Exercise

Transaction value
$0
Shares
-45,365
Change %
-100%
Price
$0.000000
Shares after
0
Date
29 Sep 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
45,365
Exercise price
$63.40
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Represents the exercise of Stock Appreciation Rights ("SARs") expiring on July 1, 2026, for which the reporting person exercised all 45,365 shares.

Footnote F2

This represents the difference between the number of SARs exercised (45,365) and the number of shares issued as a result of the exercise (14,994). The number of shares to be issued under a SAR exercise is determined by multiplying the number of SARs being exercised by the difference between the market value on the date of exercise ($94.71) and the exercise price ($63.40).

Footnote F3

Represents shares of common stock sold in the open market on September 29, 2025 pursuant to a 10b5-1 Plan adopted by the reporting person on 06/30/2025.

Footnote F4

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.33 to $94.89, inclusive. The reporting person undertakes to provide to Company, any securityholder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range specified herein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .